Head-to-head comparison of contemporary heart failure risk scores

被引:41
作者
Codina, Pau [1 ,2 ]
Lupon, Josep [1 ,2 ,3 ]
Borrellas, Andrea [1 ]
Spitaleri, Giosafat [1 ]
Cediel, German [1 ,2 ]
Domingo, Mar [1 ]
Simpson, Joanne [4 ]
Levy, Wayne C. [5 ]
Santiago-Vacas, Evelyn [1 ,3 ]
Zamora, Elisabet [1 ,2 ,3 ]
Buchaca, David [6 ]
Subirana, Isaac [7 ]
Santesmases, Javier [1 ,2 ]
Diez-Quevedo, Crisanto [1 ]
Troya, Maria, I [1 ]
Boldo, Maria [1 ]
Altmir, Salvador [1 ]
Alonso, Nuria [1 ]
Gonzalez, Beatriz [1 ]
Rivas, Carmen [1 ]
Nunez, Julio [3 ,8 ,9 ]
McMurray, John [4 ]
Bayes-Genis, Antoni [1 ,2 ,3 ]
机构
[1] Univ Hosp Germans Trias & Pujol, Heart Failure Clin & Cardiol Serv, Badalona, Spain
[2] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[3] Inst Salud Carlos III, CIBERCV, Madrid, Spain
[4] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[5] Univ Washington, UW Med Heart Inst, Seattle, WA 98195 USA
[6] Barcelona Supercomp Ctr, Barcelona, Spain
[7] Hosp Mar Med Res Inst IMIM, Barcelona, Spain
[8] Hosp Clin Univ, INCLIVA Valencia, Cardiol Dept, Valencia, Spain
[9] Univ Valencia, Dept Med, Valencia, Spain
关键词
Heart failure; Mortality; Risk models; Risk prediction; BRAIN NATRIURETIC PEPTIDE; PREDICTING SURVIVAL; VALIDATION; MODEL;
D O I
10.1002/ejhf.2352
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Several heart failure (HF) web-based risk scores are currently used in clinical practice. Currently, we lack head-to-head comparison of the accuracy of risk scores. This study aimed to assess correlation and mortality prediction performance of Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC-HF) risk score, which includes clinical variables + medications; Seattle Heart Failure Model (SHFM), which includes clinical variables + treatments + analytes; PARADIGM Risk of Events and Death in the Contemporary Treatment of Heart Failure (PREDICT-HF) and Barcelona Bio-Heart Failure (BCN-Bio-HF) risk calculator, which also include biomarkers, like N-terminal pro B-type natriuretic peptide (NT-proBNP). Methods and results A total of 1166 consecutive patients with HF from different aetiologies that had NT-proBNP measurement at first visit were included. Discrimination for all-cause mortality was compared by Harrell's C-statistic from 1 to 5 years, when possible. Calibration was assessed by calibration plots and Hosmer-Lemeshow test and global performance by Nagelkerke's R-2. Correlation between scores was assessed by Spearman rank test. Correlation between the scores was relatively poor (rho value from 0.66 to 0.79). Discrimination analyses showed better results for 1-year mortality than for longer follow-up (SHFM 0.817, MAGGIC-HF 0.801, PREDICT-HF 0.799, BCN-Bio-HF 0.830). MAGGIC-HF showed the best calibration, BCN-Bio-HF overestimated risk while SHFM and PREDICT-HF underestimated it. BCN-Bio-HF provided the best discrimination and overall performance at every time-point. Conclusions None of the contemporary risk scores examined showed a clear superiority over the rest. BCN-Bio-HF calculator provided the best discrimination and overall performance with overestimation of risk. MAGGIC-HF showed the best calibration, and SHFM and PREDICT-HF tended to underestimate risk. Regular updating and recalibration of online web calculators seems necessary to improve their accuracy as HF management evolves at unprecedented pace.
引用
收藏
页码:2035 / 2044
页数:10
相关论文
共 16 条
[1]   N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure [J].
Arzilli, Chiara ;
Aimo, Alberto ;
Vergaro, Giuseppe ;
Ripoli, Andrea ;
Senni, Michele ;
Emdin, Michele ;
Passino, Claudio .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (08) :889-895
[2]   N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J].
Bettencourt, P ;
Azevedo, A ;
Pimenta, J ;
Frioes, F ;
Ferreira, S ;
Ferreira, A .
CIRCULATION, 2004, 110 (15) :2168-2174
[3]   Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure - A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial [J].
Hartmann, F ;
Packer, M ;
Coats, AJS ;
Fowler, MB ;
Krum, H ;
Mohacsi, P ;
Rouleau, JL ;
Tendera, M ;
Castaigne, A ;
Anker, SD ;
Amann-Zalan, I ;
Hoersch, S ;
Katus, HA .
CIRCULATION, 2004, 110 (13) :1780-1786
[4]   Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure [J].
Khanam, Sayma Sabrina ;
Choi, Eunhee ;
Son, Jung-Woo ;
Lee, Jun-Won ;
Youn, Young Jin ;
Yoon, Junghan ;
Lee, Seung-Hwan ;
Kim, Jang-Young ;
Ahn, Sung Gyun ;
Min, Min-Soo ;
Kang, Seok-Min ;
Baek, Sang Hong ;
Jeon, Eun-Seok ;
Kim, Jae-Joong ;
Cho, Myeong-Chan ;
Chae, Shung Chull ;
Oh, Byung-Hee ;
Choi, Dong-Ju ;
Yoo, Byung-Su .
PLOS ONE, 2018, 13 (11)
[5]   The Seattle heart failure model - Prediction of survival in heart failure [J].
Levy, WC ;
Mozaffarian, D ;
Linker, DT ;
Sutradhar, SC ;
Anker, SD ;
Cropp, AB ;
Anand, I ;
Maggioni, A ;
Burton, P ;
Sullivan, MD ;
Pitt, B ;
Poole-Wilson, PA ;
Mann, DL ;
Packer, M .
CIRCULATION, 2006, 113 (11) :1424-1433
[6]   Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure [J].
Lupon, Josep ;
Gavidia-Bovadilla, Giovana ;
Ferrer, Elena ;
de Antonio, Marta ;
Perera-Lluna, Alexandre ;
Lopez-Ayerbe, Jorge ;
Domingo, Mar ;
Nunez, Julio ;
Zamora, Elisabet ;
Moliner, Pedro ;
Diaz-Ruata, Patricia ;
Santesmases, Javier ;
Bayes-Genis, Antoni .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (06) :591-601
[7]   Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization [J].
Lupon, Josep ;
Simpson, Joanne ;
McMurray, John J. V. ;
de Antonio, Marta ;
Vila, Joan ;
Subirana, Isaac ;
Barallat, Jaume ;
Moliner, Pedro ;
Domingo, Mar ;
Zamora, Elisabet ;
Bayes-Genis, Antoni .
EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (05) :938-940
[8]   Validation of the Barcelona Bio-Heart Failure Risk Calculator in a Cohort From Boston [J].
Lupon, Josep ;
Januzzi, James L. ;
de Antonio, Marta ;
Vila, Joan ;
Penafilel, Judith ;
Bayes-Genis, Antoni .
REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (01) :80-81
[9]   Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator) [J].
Lupon, Josep ;
de Antonio, Marta ;
Vila, Joan ;
Penafiel, Judith ;
Galan, Amparo ;
Zamora, Elisabet ;
Urrutia, Agustin ;
Bayes-Genis, Antoni .
PLOS ONE, 2014, 9 (01)
[10]   2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [J].
Ponikowski, Piotr ;
Voors, Adriaan A. ;
Anker, Stefan D. ;
Bueno, Hector ;
Cleland, John G. F. ;
Coats, Andrew J. S. ;
Falk, Volkmar ;
Ramon Gonzalez-Juanatey, Jose ;
Harjola, Veli-Pekka ;
Jankowska, Ewa A. ;
Jessup, Mariell ;
Linde, Cecilia ;
Nihoyannopoulos, Petros ;
Parissis, John T. ;
Pieske, Burkert ;
Riley, Jillian P. ;
Rosano, Giuseppe M. C. ;
Ruilope, Luis M. ;
Ruschitzka, Frank ;
Rutten, Frans H. ;
van der Meer, Peter .
EUROPEAN HEART JOURNAL, 2016, 37 (27) :2129-U130